.Merck defeats incomes requirements, rears purchases outlook on solid demand for top medications like Keytruda CNBCMerck & Co. (MRK United States) Defeats Profit Estimates as Keytruda Sales Surge BloombergMerck Supply: Pharma Giant Posts Tough Results, But Expectation Falls Short Financier's Organization DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck defeats earnings as well as sales expectations surrounded by Keytruda asset, but supplies combined full-year expectation MarketWatch.